OpenGeneral StudyTreatment Study

Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD

For Condition: ADHD

ID: NCT07784348

Horizon Patient Guidance Summary

Our intelligence engine has synthesized this trial record to answer your most important questions in clear, simple terms:

How it’s taken

Pills / Oral Tablets

Expected Availability Horizon

General Study

StageGeneral evaluation study exploring treatment methods.

EligibleThis study is looking exclusively for patients diagnosed with the condition.

About This Clinical Trial

Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET), followed by a randomized controlled trial of CET+BPT for young children with ADHD.

Read Full Scientific Objectives & Methods

Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET) \[R61 Phase\], followed by a randomized controlled trial of CET+BPT for young children with ADHD \[R33 Phase\].

Study Timeline & Quick Facts

Trial Status

Open — Looking for Participants

Total Target Enrollment

120 patients (Estimated)

Study Start Date

2024-05-01

Est. Primary Completion

2030-12

Tested Drugs & Treatment Groups

BEHAVIORALCentral executive training

Computerized, adaptive central executive working memory training protocol

BEHAVIORALBehavioral parent training

Behavioral parent training

Treatment Arms Description

EXPERIMENTALCentral executive training

ACTIVE_COMPARATORBehavioral parent training

OTHERCentral executive training + concurrent behavioral parent training

NO_INTERVENTIONTreatment as usual/waitlist

Can I Join This Study?

Suitable For

Everyone welcome

Ages Welcome

Between 4 Years and 8 Years

Full Criteria Checklist

Who Can Join

principal ADHD diagnoses (via K-SADS); (b) parent BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range (\>90th percentile) based on age and sex; (c) teacher BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range based on age and sex

Who Cannot Join

(a) gross neurological, sensory, or motor impairment; (b) history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (e.g., disruptive mood dysregulation, conduct, intermittent explosive, reactive attachment); (c) intellectual disability or WPPSI/WISC short-form FSIQ\<70; (d) conditions requiring acute intervention, e.g., active suicidality; and (e) non-English speaking child or parent.

What is this Study Measuring?

Primary Outcome Measures

ADHD Rating Scale (ADHD-RS) — Time Frame: Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completion

View Secondary Outcome Measures (2)

Secondary outcomes (T-scores) — Time Frame: Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completion
Informant reports of social skills, emotion regulation, parent-child relationships, and impairments
Feasibility/acceptability — Time Frame: Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completion
Client satisfaction, system usability, expectancies

Where to Participate

This trial is recruiting at 1 study facilities worldwide. Click below to see if there is a clinic or hospital in your area:

Show All 1 Facilities & Contact Sites

Children's Learning Clinic at Florida State University

Tallahassee, Florida, United States

Status: Open

Trial Design & Scientific Setup

Allocation

randomized

Intervention Model

crossover

Primary Purpose

treatment

Masking

quadruple (participant, care_provider, investigator, outcomes_assessor)

Sponsoring Teams & Contacts

Lead Sponsoring Institution

Florida State University

Collaborators: National Institute of Mental Health (NIMH)

Primary Research Contact

Children's Learning Clinic

Tel: 850-645-7423

Email: clc@psy.fsu.edu

Clinical Trial Application Copilot

Want to apply or inquire about joining this study? Fill out this simple questionnaire, and our assistant will instantly generate a professional email draft you can copy and send to the central contact coordinator listed above!

Your Full Name

Your Age

Diagnosed Condition

Generated Professional Email Draft:

Draft ready to copy & send

Subject: Inquiry about clinical trial enrollment: NCT07784348 - Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD

Dear Study Coordinator / Research Team, I hope this message finds you well. My name is [Your Name], and I am writing to express my strong interest in participating in the clinical trial titled "Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD" (NCT ID: NCT07784348). I am [Age] years old and have been diagnosed with ADHD. I have reviewed the eligibility criteria for this study on Med Code Info and believe I may be a suitable candidate. Could you please let me know if this study is actively enrolling patients at any site near my location, and what the next steps are to undergo screening? Thank you for your time and research efforts. Warm regards, [Your Name]

View Official Medical/Scientific Title

Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD